Category search
Search results: Grants
Published date 24 September 2026
Cancer Institute NSW has delivered $21 million across four Translational Cancer Research Capacity Building Grants to strengthen collaborative cancer research and drive better outcomes for communities across NSW.
Published date 21 September 2026
Research to improve the quality of life and outcomes of children with an inherited cancer risk is among three initiatives sharing more than $700,000 in Nursing Fellowship grants.
Published date 26 August 2026
The Cancer Institute NSW is proud to support the National Breast Cancer Foundation’s (NBCF) inaugural Pink Sky Grants Scheme, contributing $500,000 towards innovative NSW research projects that aim to reduce the impact of breast cancer.
Published date 25 June 2026
A new Cancer Institute NSW outpatient survey reveals people with cancer across NSW are overwhelming satisfied with the experience of care provided at the state’s outpatient cancer services.
Published date 20 May 2026
Cancer Institute NSW is supporting the work of 18 early and mid-career researchers across the state, to strengthen and expand research that could shape the future of cancer care.
Published date 24 April 2026
Two grants valued at $3.75 million each have been awarded by Cancer Institute NSW to support research, which aims to rapidly improve cancer care and outcomes across the state.
Published date 25 March 2026
More than $1.2 million in new funding will help more people access cervical screening and reduce their risk of cervical cancer.
Published date 13 March 2026
A BreastScreen NSW campaign has been relaunched after breast screening bookings surged by 22 per cent, or an additional 12,000 women, in NSW last year.
Published date 30 January 2026
Cancer Institute NSW has awarded $1.8 million in research equipment grants to accelerate research and improve cancer outcomes for people across NSW.
Published date 20 May 2025
An innovative project is training bilingual educators to act as ‘navigators’ to support Arabic speaking cancer patients through the clinical trials process by reducing language and cultural barriers.